Arcutis names Rob Lisicki chief commercial officer
ARQT•Arcutis appointed Rob Lisicki chief commercial officer effective November 4, 2026; Lisicki has more than 30 years of biopharmaceutical industry experience.
1. Leadership changes
Arcutis appointed Rob Lisicki chief commercial officer effective November 4, 2026. Rob Scott, MD, joined the board of directors in October 2026.




